Showing results (431-440 of 915) with videos related to

Sort By:
Pageof 92
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|June 8, 2006
Carotid black blood MRI burden of atherosclerotic disease assessment correlates with ultrasound intima-media thicknessVenkatesh Mani, Silvia H Aguiar, Vitalii V Itskovich, et al.
JACC. Cardiovascular Imaging|May 19, 2012
Feasibility of [18F]-2-Fluoro-A85380-PET imaging of human vascular nicotinic acetylcholine receptors in vivoJan Bucerius, Christoph Manka, Jörn Schmaljohann, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 22, 2021
Targeting Trained Innate Immunity With Nanobiologics to Treat Cardiovascular DiseaseAbraham J P Teunissen, Mandy M T van Leent, Geoffrey Prévot, et al.
Nano Today|March 9, 2016
Nanomedicines for Endothelial DisordersBomy Lee Chung, Michael J Toth, Nazila Kamaly, et al.
JMIR Formative Research|October 26, 2023
A Hybrid Decision Tree and Deep Learning Approach Combining Medical Imaging and Electronic Medical Records to Predict Intubation Among Hospitalized Patients With COVID-19: Algorithm Development and ValidationKim-Anh-Nhi Nguyen, Pranai Tandon, Sahar Ghanavati, et al.
JACC. Cardiovascular Imaging|January 14, 2012
Correlation between arterial FDG uptake and biomarkers in peripheral artery diseaseKelly S Myers, James H F Rudd, Eric P Hailman, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|May 28, 2021
Scan-rescan measurement repeatability of 18F-FDG PET/MR imaging of vascular inflammationPhilip M Robson, Audrey Kaufman, Alison Pruzan, et al.
Biomaterials|September 29, 2009
Iron oxide core oil-in-water emulsions as a multifunctional nanoparticle platform for tumor targeting and imagingPeter A Jarzyna, Torjus Skajaa, Anita Gianella, et al.
European Heart Journal|January 11, 2021
A leucopoietic-arterial axis underlying the link between ambient air pollution and cardiovascular disease in humansShady Abohashem, Michael T Osborne, Tawseef Dar, et al.
Atherosclerosis|March 11, 2015
A phase 2 randomized, double-blind, placebo-controlled study of the effect of VIA-2291, a 5-lipoxygenase inhibitor, on vascular inflammation in patients after an acute coronary syndromeJuan Gaztanaga, Michael Farkouh, James H F Rudd, et al.
Pageof 92